Trends

Medicine & Biotech · covered by 16 outlets this week · tracked since 2026-10-27

Press: 4 mainstream 35 specialist outlet-days

Coverage

study

STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

STAT Biotech · 5h ago

study

Drug price hikes in Germany could push US costs higher, study says

BioPharma Dive · 9h ago

How government allows patients to be looted

Down To Earth Health · 14h ago

STAT+: Democrats take new step toward investigating Trump’s drug pricing deals

STAT Politics (health policy) · 1d ago

Democrats escalate probe of Trump admin drug pricing deals

The Hill Healthcare · 1d ago

study

STAT+: GLP-1s are given an FDA warning for rare eye condition risk

STAT News · 1d ago

study

STAT+: Gene therapy’s long-debated cancer risk materializes

STAT News · 2d ago

STAT+: Democrats begin asking: How far can we go on health care?

STAT Politics (health policy) · 2d ago

STAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries

STAT Biotech · 4d ago

studyobservational

STAT+: Amgen’s Repatha linked to fewer heart attacks

STAT Biotech · 5d ago

study

STAT+: A possible comeback for a failed sickle cell gene therapy

STAT Biotech · 6d ago

Single-payer health care system proponents were thrown a big bone this election

STAT News · 6d ago

Generic Competition and Drug Prices

FDA Drug Safety / Drugs feed · 6d ago

The page says $249 a month. The math says $747.

The Health Care Blog · 7d ago

STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill

STAT Biotech · 7d ago

Biopharma likely to climb higher after ‘blue wave,’ analysts say

BioPharma Dive · 7d ago

study

STAT+: Ultragenyx cuts staff after another study fails

STAT Biotech · 7d ago

study

STAT+: Who will get the first psychedelic approved?

STAT Biotech · 8d ago

studyin animals

STAT+: Psilocybin’s lasting benefits prove elusive in mice

STAT Biotech · 9d ago

The trust-busters going after CVS are Republicans

Politico Health Care · 10d ago

“Pricing needs to be considered carefully in the context of the global market”

BioSpectrum India · 10d ago

STAT+: New federal rule will require prescription drug middlemen to share secret payments data

STAT Politics (health policy) · 13d ago

study

STAT+: HHS green lights six peptides, despite concerns from FDA scientists

STAT Biotech · 13d ago

study

STAT+: Lilly’s triple-G drug beats Ozempic in head-to-head study

STAT Biotech · 14d ago

study

STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down

STAT Biotech · 15d ago

study

STAT+: Five biotech updates to read after ESMO this weekend

STAT News · 16d ago

Open enrollment begins: What Medicare beneficiaries need to know for 2027

The Hill Healthcare · 16d ago

explainer

How Do I Know if My Medications and Drugs Are Covered by Insurance?

Everyday Health · 21d ago

How TrumpRx brand-name drug prices compare to other countries

Peterson-KFF Health System Tracker · 48d ago

When Drug Price Transparency Isn’t Enough

The Incidental Economist · 337d ago

Trump’s Prescription Drug Policy: Rhetoric vs. True Reform

The Incidental Economist · 378d ago

We Need Congress to Get Serious About Lowering Drug Costs

The Incidental Economist · 398d ago

podcast

Prescription drug prices are high. What gives? (WBEZ)

An Arm and a Leg · 456d ago

Measuring Biopharmaceutical Innovation in the Modern Era

The Incidental Economist · 457d ago

A Primer on Pharmacy Benefit Managers

The Incidental Economist · 525d ago

Trump’s Return Puts Inflation Reduction Act in Jeopardy

The Incidental Economist · 657d ago

Medicare Drug Price Negotiations

The Incidental Economist · 737d ago

Paying to Breathe: Asthma in America

The Incidental Economist · 740d ago

explainer

Why Do Americans Pay SO Much More for Prescription Drugs?

The Incidental Economist · 792d ago

podcast

Episodes of An Arm and a Leg

An Arm and a Leg · 2648d ago